Youla Tsantrizos, Ph.D.
Affiliations: | 1997- | Chemistry | McGill University, Montreal, QC, Canada |
Area:
CrystallographyWebsite:
http://tsantrizos-group.mcgill.ca/tsantrizos.htmlGoogle:
"Youla Tsantrizos"Bio:
2012 - Queen Elizabeth II Diamond Jubilee Medal "for services to Canada"
Mean distance: 7.89 | S | N | B | C | P |
Cross-listing: Crystallography Tree
Parents
Sign in to add mentor| George Just | grad student | 1977-1979 | McGill |
| Kelvin K. Ogilvie | grad student | 1987-1990 | McGill |
| David E. Cane | post-doc | 1990-1991 | Brown |
Children
Sign in to add trainee| Xian-Shu Yang | grad student | 2000 | McGill |
| Lee D. Fader | grad student | 2002 | McGill |
| J. De Schutter | grad student | 2013 | McGill |
| Yih-Shyan Lin | grad student | 2014 | McGill |
| Warren Chew | post-doc | 1996 | McGill |
| John Mancuso | post-doc | 2009-2010 | McGill |
| Olivier Leogane | post-doc | 2011-2012 | McGill |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Lee HF, Lacbay CM, Boutin R, et al. (2022) Synthesis and Evaluation of Structurally Diverse C-2-Substituted Thienopyrimidine-Based Inhibitors of the Human Geranylgeranyl Pyrophosphate Synthase. Journal of Medicinal Chemistry |
| Park J, Rodionov D, De Schutter JW, et al. (2017) Crystallographic and thermodynamic characterization of phenylaminopyridine bisphosphonates binding to human farnesyl pyrophosphate synthase. Plos One. 12: e0186447 |
| Fader LD, Bailey M, Beaulieu E, et al. (2016) Aligning Potency and Pharmacokinetic Properties for Pyridine-Based NCINIs. Acs Medicinal Chemistry Letters. 7: 797-801 |
| Jansen G, Golizeh M, Martel-Lorion C, et al. (2016) A covalent cysteine-targeting kinase inhibitor of Ire1 permits allosteric control of endoribonuclease activity. Chembiochem : a European Journal of Chemical Biology |
| Fandrick KR, Li W, Zhang Y, et al. (2015) Concise and Practical Asymmetric Synthesis of a Challenging Atropisomeric HIV Integrase Inhibitor. Angewandte Chemie (International Ed. in English). 54: 7144-8 |
| Gritzalis D, Park J, Chiu W, et al. (2015) Probing the molecular and structural elements of ligands binding to the active site versus an allosteric pocket of the human farnesyl pyrophosphate synthase. Bioorganic & Medicinal Chemistry Letters. 25: 1117-23 |
| Lacbay CM, Mancuso J, Lin YS, et al. (2014) Modular assembly of purine-like bisphosphonates as inhibitors of HIV-1 reverse transcriptase. Journal of Medicinal Chemistry. 57: 7435-49 |
| Fader LD, Carson R, Morin S, et al. (2014) Minimizing the Contribution of Enterohepatic Recirculation to Clearance in Rat for the NCINI Class of Inhibitors of HIV. Acs Medicinal Chemistry Letters. 5: 711-6 |
| De Schutter JW, Park J, Leung CY, et al. (2014) Multistage screening reveals chameleon ligands of the human farnesyl pyrophosphate synthase: implications to drug discovery for neurodegenerative diseases. Journal of Medicinal Chemistry. 57: 5764-76 |
| Fader LD, Malenfant E, Parisien M, et al. (2014) Discovery of BI 224436, a Noncatalytic Site Integrase Inhibitor (NCINI) of HIV-1. Acs Medicinal Chemistry Letters. 5: 422-7 |